
Next-Generation Oncology Devices & Solutions Market by Component (Devices, Software), Cancer Type (Breast Cancer, Cervical Cancer, Colorectal Cancer), End User - Global Forecast 2024-2030
Description
Next-Generation Oncology Devices & Solutions Market by Component (Devices, Software), Cancer Type (Breast Cancer, Cervical Cancer, Colorectal Cancer), End User - Global Forecast 2024-2030
The Next-Generation Oncology Devices & Solutions Market size was estimated at USD 15.62 billion in 2023 and expected to reach USD 18.97 billion in 2024, at a CAGR 21.15% to reach USD 59.84 billion by 2030.
FPNV Positioning Matrix
The FPNV Positioning Matrix is pivotal in evaluating the Next-Generation Oncology Devices & Solutions Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).
Market Share Analysis
The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the Next-Generation Oncology Devices & Solutions Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.
Key Company Profiles
The report delves into recent significant developments in the Next-Generation Oncology Devices & Solutions Market, highlighting leading vendors and their innovative profiles. These include Abbott Laboratories, Agilent Technologies, Inc., Bio-Rad Laboratories, Inc., Brainlab, Danaher Corporation, Exact Sciences Corp., F. Hoffmann-La Roche Ltd., GE HealthCare Technologies, Inc., Guardant Health Inc., Hologic, Inc., Illumina, Inc., Johnson & Johnson Services Inc., Merck & Co., Inc., Myriad Genetics, Inc., NanoString Technologies, Inc., Natera, Inc., NeoGenomics, Inc., Novartis AG, Paige.AI, Inc., PerkinElmer, Inc., QIAGEN N.V., Quest Diagnostics Incorporated, Royal Philips, Siemens AG, Sysmex Corporation, Takara Bio USA, Inc., Thermo Fisher Scientific Inc., and Veracyte, Inc..
Market Segmentation & Coverage
This research report categorizes the Next-Generation Oncology Devices & Solutions Market to forecast the revenues and analyze trends in each of the following sub-markets:
Component
Devices
Advanced Forms of Radiation Therapy
High-Intensity Focused Ultrasound
Software
Cancer Type
Breast Cancer
Cervical Cancer
Colorectal Cancer
Lung Cancer
End User
Diagnostic Imaging Centers
Hospitals
Region
Americas
Argentina
Brazil
Canada
Mexico
United States
California
Florida
Illinois
New York
Ohio
Pennsylvania
Texas
Asia-Pacific
Australia
China
India
Indonesia
Japan
Malaysia
Philippines
Singapore
South Korea
Taiwan
Thailand
Vietnam
Europe, Middle East & Africa
Denmark
Egypt
Finland
France
Germany
Israel
Italy
Netherlands
Nigeria
Norway
Poland
Qatar
Russia
Saudi Arabia
South Africa
Spain
Sweden
Switzerland
Turkey
United Arab Emirates
United Kingdom
The report offers valuable insights on the following aspects:
1. Market Penetration: It presents comprehensive information on the market provided by key players.
2. Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.
3. Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.
4. Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.
5. Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.
The report addresses key questions such as:
1. What is the market size and forecast of the Next-Generation Oncology Devices & Solutions Market?
2. Which products, segments, applications, and areas should one consider investing in over the forecast period in the Next-Generation Oncology Devices & Solutions Market?
3. What are the technology trends and regulatory frameworks in the Next-Generation Oncology Devices & Solutions Market?
4. What is the market share of the leading vendors in the Next-Generation Oncology Devices & Solutions Market?
5. Which modes and strategic moves are suitable for entering the Next-Generation Oncology Devices & Solutions Market?
Note: PDF & Excel + Online Access - 1 Year
Table of Contents
186 Pages
- 1. Preface
- 1.1. Objectives of the Study
- 1.2. Market Segmentation & Coverage
- 1.3. Years Considered for the Study
- 1.4. Currency & Pricing
- 1.5. Language
- 1.6. Limitations
- 1.7. Assumptions
- 1.8. Stakeholders
- 2. Research Methodology
- 2.1. Define: Research Objective
- 2.2. Determine: Research Design
- 2.3. Prepare: Research Instrument
- 2.4. Collect: Data Source
- 2.5. Analyze: Data Interpretation
- 2.6. Formulate: Data Verification
- 2.7. Publish: Research Report
- 2.8. Repeat: Report Update
- 3. Executive Summary
- 4. Market Overview
- 4.1. Introduction
- 4.2. Next-Generation Oncology Devices & Solutions Market, by Region
- 5. Market Insights
- 5.1. Market Dynamics
- 5.1.1. Drivers
- 5.1.1.1. Growing prevalence of cancer across the globe
- 5.1.1.2. Rising preference for minimally invasive techniques of diagnosis and treatment
- 5.1.1.3. Government Initiatives to improve healthcare infrastructure
- 5.1.2. Restraints
- 5.1.2.1. High initial investments for manufacturing of next generation devices
- 5.1.3. Opportunities
- 5.1.3.1. Ongoing technological advancements oncology testing and treatment
- 5.1.3.2. Proliferation of personalized and advanced genome medicine
- 5.1.4. Challenges
- 5.1.4.1. Concern associated with the insufficient standardization of diagnostics
- 5.2. Market Segmentation Analysis
- 5.3. Market Trend Analysis
- 5.4. Cumulative Impact of High Inflation
- 5.5. Porter’s Five Forces Analysis
- 5.5.1. Threat of New Entrants
- 5.5.2. Threat of Substitutes
- 5.5.3. Bargaining Power of Customers
- 5.5.4. Bargaining Power of Suppliers
- 5.5.5. Industry Rivalry
- 5.6. Value Chain & Critical Path Analysis
- 5.7. Regulatory Framework
- 6. Next-Generation Oncology Devices & Solutions Market, by Component
- 6.1. Introduction
- 6.2. Devices
- 6.3.1. Advanced Forms of Radiation Therapy
- 6.3.2. High-Intensity Focused Ultrasound
- 6.3. Software
- 7. Next-Generation Oncology Devices & Solutions Market, by Cancer Type
- 7.1. Introduction
- 7.2. Breast Cancer
- 7.3. Cervical Cancer
- 7.4. Colorectal Cancer
- 7.5. Lung Cancer
- 8. Next-Generation Oncology Devices & Solutions Market, by End User
- 8.1. Introduction
- 8.2. Diagnostic Imaging Centers
- 8.3. Hospitals
- 9. Americas Next-Generation Oncology Devices & Solutions Market
- 9.1. Introduction
- 9.2. Argentina
- 9.3. Brazil
- 9.4. Canada
- 9.5. Mexico
- 9.6. United States
- 10. Asia-Pacific Next-Generation Oncology Devices & Solutions Market
- 10.1. Introduction
- 10.2. Australia
- 10.3. China
- 10.4. India
- 10.5. Indonesia
- 10.6. Japan
- 10.7. Malaysia
- 10.8. Philippines
- 10.9. Singapore
- 10.10. South Korea
- 10.11. Taiwan
- 10.12. Thailand
- 10.13. Vietnam
- 11. Europe, Middle East & Africa Next-Generation Oncology Devices & Solutions Market
- 11.1. Introduction
- 11.2. Denmark
- 11.3. Egypt
- 11.4. Finland
- 11.5. France
- 11.6. Germany
- 11.7. Israel
- 11.8. Italy
- 11.9. Netherlands
- 11.10. Nigeria
- 11.11. Norway
- 11.12. Poland
- 11.13. Qatar
- 11.14. Russia
- 11.15. Saudi Arabia
- 11.16. South Africa
- 11.17. Spain
- 11.18. Sweden
- 11.19. Switzerland
- 11.20. Turkey
- 11.21. United Arab Emirates
- 11.22. United Kingdom
- 12. Competitive Landscape
- 12.1. FPNV Positioning Matrix
- 12.2. Market Share Analysis, By Key Player
- 12.3. Competitive Scenario Analysis, By Key Player
- 13. Competitive Portfolio
- 13.1. Key Company Profiles
- 13.1.1. Abbott Laboratories
- 13.1.2. Agilent Technologies, Inc.
- 13.1.3. Bio-Rad Laboratories, Inc.
- 13.1.4. Brainlab
- 13.1.5. Danaher Corporation
- 13.1.6. Exact Sciences Corp.
- 13.1.7. F. Hoffmann-La Roche Ltd.
- 13.1.8. GE HealthCare Technologies, Inc.
- 13.1.9. Guardant Health Inc.
- 13.1.10. Hologic, Inc.
- 13.1.11. Illumina, Inc.
- 13.1.12. Johnson & Johnson Services Inc.
- 13.1.13. Merck & Co., Inc.
- 13.1.14. Myriad Genetics, Inc.
- 13.1.15. NanoString Technologies, Inc.
- 13.1.16. Natera, Inc.
- 13.1.17. NeoGenomics, Inc.
- 13.1.18. Novartis AG
- 13.1.19. Paige.AI, Inc.
- 13.1.20. PerkinElmer, Inc.
- 13.1.21. QIAGEN N.V.
- 13.1.22. Quest Diagnostics Incorporated
- 13.1.23. Royal Philips
- 13.1.24. Siemens AG
- 13.1.25. Sysmex Corporation
- 13.1.26. Takara Bio USA, Inc.
- 13.1.27. Thermo Fisher Scientific Inc.
- 13.1.28. Veracyte, Inc.
- 13.2. Key Product Portfolio
- 14. Appendix
- 14.1. Discussion Guide
- 14.2. License & Pricing
- FIGURE 1. NEXT-GENERATION ONCOLOGY DEVICES & SOLUTIONS MARKET RESEARCH PROCESS
- FIGURE 2. NEXT-GENERATION ONCOLOGY DEVICES & SOLUTIONS MARKET SIZE, 2023 VS 2030
- FIGURE 3. NEXT-GENERATION ONCOLOGY DEVICES & SOLUTIONS MARKET SIZE, 2018-2030 (USD MILLION)
- FIGURE 4. NEXT-GENERATION ONCOLOGY DEVICES & SOLUTIONS MARKET SIZE, BY REGION, 2023 VS 2030 (%)
- FIGURE 5. NEXT-GENERATION ONCOLOGY DEVICES & SOLUTIONS MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
- FIGURE 6. NEXT-GENERATION ONCOLOGY DEVICES & SOLUTIONS MARKET DYNAMICS
- FIGURE 7. NEXT-GENERATION ONCOLOGY DEVICES & SOLUTIONS MARKET SIZE, BY COMPONENT, 2023 VS 2030 (%)
- FIGURE 8. NEXT-GENERATION ONCOLOGY DEVICES & SOLUTIONS MARKET SIZE, BY COMPONENT, 2023 VS 2024 VS 2030 (USD MILLION)
- FIGURE 9. NEXT-GENERATION ONCOLOGY DEVICES & SOLUTIONS MARKET SIZE, BY CANCER TYPE, 2023 VS 2030 (%)
- FIGURE 10. NEXT-GENERATION ONCOLOGY DEVICES & SOLUTIONS MARKET SIZE, BY CANCER TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
- FIGURE 11. NEXT-GENERATION ONCOLOGY DEVICES & SOLUTIONS MARKET SIZE, BY END USER, 2023 VS 2030 (%)
- FIGURE 12. NEXT-GENERATION ONCOLOGY DEVICES & SOLUTIONS MARKET SIZE, BY END USER, 2023 VS 2024 VS 2030 (USD MILLION)
- FIGURE 13. AMERICAS NEXT-GENERATION ONCOLOGY DEVICES & SOLUTIONS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
- FIGURE 14. AMERICAS NEXT-GENERATION ONCOLOGY DEVICES & SOLUTIONS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
- FIGURE 15. UNITED STATES NEXT-GENERATION ONCOLOGY DEVICES & SOLUTIONS MARKET SIZE, BY STATE, 2023 VS 2030 (%)
- FIGURE 16. UNITED STATES NEXT-GENERATION ONCOLOGY DEVICES & SOLUTIONS MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
- FIGURE 17. ASIA-PACIFIC NEXT-GENERATION ONCOLOGY DEVICES & SOLUTIONS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
- FIGURE 18. ASIA-PACIFIC NEXT-GENERATION ONCOLOGY DEVICES & SOLUTIONS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
- FIGURE 19. EUROPE, MIDDLE EAST & AFRICA NEXT-GENERATION ONCOLOGY DEVICES & SOLUTIONS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
- FIGURE 20. EUROPE, MIDDLE EAST & AFRICA NEXT-GENERATION ONCOLOGY DEVICES & SOLUTIONS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
- FIGURE 21. NEXT-GENERATION ONCOLOGY DEVICES & SOLUTIONS MARKET, FPNV POSITIONING MATRIX, 2023
- FIGURE 22. NEXT-GENERATION ONCOLOGY DEVICES & SOLUTIONS MARKET SHARE, BY KEY PLAYER, 2023
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.